research¶

Grounded examples for the research domain.

Instances¶

Adolescent voice-diary raw-audio retention exception approval packet for research data governance council review
A research data governance manager must assemble a decision-ready approval packet because the scheduled destruction of raw audio from the adolescent voice-diary study cannot proceed on time after a transcription quality recheck and derivative-embedding inventory mismatch leave a bounded request to retain the restricted recordings for an additional ninety days pending research data governance council review. The workflow assembles one exact governed packet, AVD-Retention-Exception-Packet-v4, and gives source precedence to the approved study protocol amendment, signed participant consent and withdrawal schedule, the institutional restricted-audio retention standard, and the latest IRB continuing-review condition over the storage inventory snapshot, transcription completion dashboard, vault purge telemetry, secure-erase work order notes, and analyst annotations. Packet assembly may begin only after study enrollment is closed, transcript QA sign-off is recorded, the current restricted reviewer roster is frozen, and the prior packet revision AVD-Retention-Exception-Packet-v3 is marked returned for rework; agents keep visible blockers such as Site 3 withdrawal coding still under reconciliation, a missing cold-vault erase certificate for one replica, and disputed derivative-embedding disposal coverage in an explicit exception register while preserving the revision lineage under named owner Priya Nandakumar. The workflow stops at packet generation and handoff; it does not recommend whether the retention exception should be granted, adjudicate participant-risk acceptability, amend the protocol, notify participants or sites, enable additional data access, or execute any retention, deletion, or downstream study action. mermaid flowchart TD A["Scoped raw-audio retention exception request and packet boundary confirmed"] --> B["Gather protocol, consent, retention-standard, IRB condition, storage inventory, purge telemetry, derivative inventory, and prior packet lineage"] B --> C["Assemble approval packet, provenance index, and exception register"] C --> D{"Packet assembly checks complete, sourced, and reviewer-ready?"} D -- "No: evidence missing or disposal coverage disputed" --> E["Hold for source completion and keep retention blockers explicit"] D -- "No: scope or reviewer routing unclear" --> F["Hold for study-scope or council clarification before handoff"] E --> B F --> C D -- "Yes" --> G["Create handoff record with named research-data-governance reviewers, packet version, completeness state, and unresolved blockers"] G --> H["Bounded transfer to review-routing queue for council evaluation only"]
Applied-study data-collection schedule replanning after recruitment delay or site-capacity constraint
An applied research program already has an approved data-collection plan that sequences site activation, screening ramp checks, cohort recruitment targets, protocol-defined visit windows, specimen-processing cutoffs, source-data verification preparation, and a fixed interim data-cut handoff for internal analysis planning. Then the baseline plan stops being feasible: recruitment at one site lags below the expected accrual curve, a high-volume site loses coordinator capacity for several weeks, or both shifts compress the original path to the interim data cut without changing the non-waivable visit-window rules. The workflow should recompute a revised data-collection timeline, document which site milestones can move and which checkpoints must stay fixed, and prepare a coordination-ready replanning packet for the study operations lead, site managers, recruitment analytics partner, data management lead, and biostatistics liaison rather than deciding whether enrollment criteria should change, approving a protocol amendment, contacting participants, or executing the revised collection plan itself. mermaid flowchart TD A["Recruitment delay or site-capacity constraint detected"] B["Refresh baseline collection plan, site accrual state, visit-window status, and fixed data-cut checkpoints"] C["Verify source freshness, capacity assumptions, and non-waivable study constraints"] D{"Any in-policy revised schedule preserves visit-window rules and the fixed interim data-cut handoff?"} E["Build revised data-collection timeline with resequenced site and cohort milestones"] F["Record moved milestones, fixed checkpoints, blocked alternatives, and residual timing risk"] G["Assemble coordination-ready replanning packet"] H["Study operations lead and required partners review for adoption"] I["Hold with escalation packet for infeasible constraints or uncertain inputs"] A -->|"Refresh current study state"| B B -->|"Run verification checks"| C C -->|"Fresh and usable"| D C -->|"Stale or uncertain inputs"| I D -->|"Yes"| E D -->|"No"| I E -->|"Document impacts"| F F -->|"Prepare handoff"| G G -->|"Route for adoption"| H I -->|"Escalate within planning boundary"| H
Approved benchmark study publication-integrity packet evidence gate verification
A research publication-operations team already has one approved publication-integrity packet revision for a benchmark study, but that exact packet cannot be released into the restricted integrity-review lane until current evidence still supports human reliance on it. The workflow rechecks rerun-manifest lineage, dataset-rights clearance freshness, disclosure-review state, embargo controls, annex hashes, and named reviewer scope against the approved packet, then emits a verified, held, or insufficient verdict with explicit evidence lineage and release-hold state for research governance approvers. It must not refresh the packet, recommend whether the study should be published, submit a manuscript, repair missing evidence, or start downstream review execution. mermaid flowchart TD start["Approved benchmark-study publication-integrity packet revision"] verify["Recheck rerun-manifest lineage, dataset-rights clearance freshness, disclosure-review state, embargo controls, annex hashes, and named reviewer scope"] assess{"Does current evidence still support the exact approved packet revision?"} verified["Emit verified verdict with evidence lineage"] held["Emit held verdict for stale rights clearance, superseded rerun-manifest lineage, disclosure drift, embargo-control change, annex mismatch, or reviewer-scope drift"] insufficient["Emit insufficient verdict for material evidence conflict or missing corroboration"] state["Emit release-hold state and evidence lineage for research governance approvers"] stop["Stop before restricted integrity-review lane release"] start --> verify verify --> assess assess -->|"yes"| verified assess -->|"stale or boundary drift"| held assess -->|"material conflict"| insufficient verified --> state held --> state insufficient --> state state --> stop
Approved benchmark study review disposition closure
An internal research-governance council records that a multimodal benchmark study is approved for internal catalog inclusion after reviewers finish reproducibility, licensing, and disclosure checks. The decision itself is already final in the review system. The remaining workflow is low-risk downstream completion: detect the authoritative approval event, recheck that the study identifier and approved disposition are still current, update the internal study registry, attach the final review packet hash to the catalog record, archive the approved evidence bundle, close the intake checklist, and notify the study owners that the review is complete. The workflow must not publish the work externally, change the approved disposition, or infer any new release decision beyond the recorded council outcome. mermaid flowchart TD A["Authoritative approval event received from review system"] B["Recheck current study identifier and approved disposition"] C["Update internal study registry and attach final packet hash"] D["Archive approved evidence bundle for closure record"] E["Close intake checklist and record completion trace"] F["Notify study owners that review closure is complete"] A --> B B --> C C --> D D --> E E --> F
Approved human-subjects continuing-review closure and protocol-registry synchronization
A university-affiliated research compliance office has already recorded an approved continuing-review disposition for a longitudinal human-subjects study in the authoritative ethics workflow after the board completed its decision-making work. That approval is final for this workflow and must not be reopened, reinterpreted, or extended into participant-facing study execution. The remaining execute step is limited to low-risk closure bookkeeping: detect the approved continuing-review event, recheck that the protocol identifier, approval term, and approved packet references still match the source record, close the annual review queue item, sync the internal protocol registry and study-operations tracker to the recorded review-complete state, attach archive references for the final approval letter and continuing-review packet, record completion state in the audit store, and notify the study operations coordinator that review closure propagation is complete. If the protocol was reopened, the approval term changed, or the target registry points to a different study record, the workflow should stop and route manual follow-up instead of guessing. mermaid flowchart TD A["Approved continuing-review event detected"] B{"Study identifiers, approval term, and packet references still match?"} C["Close annual review queue item"] D["Sync protocol registry and study-operations tracker"] E["Attach archive references and record audit completion state"] F["Notify study operations coordinator that closure propagation is complete"] G["Stop automation and route manual follow-up"] A --> B B -->|"Yes"| C B -->|"No"| G C --> D D --> E E --> F
Approved human-subjects e-consent platform primary cutover staged execution
After the institutional review board, study sponsor operations, and research platform change authority approve promotion of a new human-subjects e-consent platform to become the primary live consent path for one active multisite study, research systems operations must execute one exact governed cutover artifact, HS-ECONSENT-PRIMARY-CUTOVER-EXEC-v4, during a controlled production window. Source precedence is explicit before execution begins: the signed cutover order and approved rollback plan outrank the IRB-approved consent package and study site-activation roster, which outrank the frozen environment baseline, parity snapshots, and lower-precedence operator notes or vendor chat. The prerequisite state is also fixed in advance: consent content is frozen, the live study configuration baseline is pinned, the legacy consent path is in controlled no-change mode, the new platform release is already deployed but dark, rollback credentials and the legacy restore bundle are verified, and the approved site cohort for limited activation is locked. Visible blockers remain attached to the execution record until cleared: Site 04 still shows one unsigned translated assent PDF in the legacy cache, participant status parity for two in-progress reconsent cases has not yet matched between platforms, and one clinic kiosk profile has not confirmed rollback-package receipt. Revision lineage from v2 through v4 remains inspectable, and Dr. Serena Malik, Director of Human Subjects Research Platforms, is accountable for staged execution quality only. The workflow stays bounded at governed cutover execution: it does not reopen approval adjudication, rewrite consent policy, design participant communications, or run downstream study enrollment operations. mermaid flowchart TD A["Approved cutover artifact `HS-ECONSENT-PRIMARY-CUTOVER-EXEC-v4` and named release authorities in force"] --> B["Run preflight checks frozen consent package, site cohort lock, parity baseline, rollback bundle, kiosk readiness"] B --> C{"Preflight evidence within approved cutover and rollback limits?"} C -- "No" --> H["Visible hold for research platform owner, study operations, and privacy review"] C -- "Yes" --> D["Activate new e-consent platform for the limited approved site cohort"] D --> E{"Enrollment, signature capture, document rendering, and participant-state parity stay healthy with rollback preserved?"} E -- "No" --> I["Restore legacy consent path for active sites and publish bounded rollback packet"] E -- "Yes" --> F["Protected human hold before promoting the new platform as primary"] F -- "Held" --> H F -- "Released" --> G["Promote the new platform to primary, keep legacy path hot, and verify cross-system parity"] G --> J{"Primary-state parity, site telemetry, and exception queue remain stable?"} J -- "No" --> I J -- "Yes" --> K["Protected final hold before retiring the legacy consent path"] K -- "Held" --> H K -- "Released" --> L["Retire legacy consent path, seal final execution ledger, and record authoritative-state confirmation"]
Approved human-subjects ethics amendment portal submission
An academic-industry research operations lead needs to submit an already approved ethics amendment for a longitudinal human-subjects study after the team adds a new wearable-derived biomarker, revises participant recontact language, and expands a data-sharing pathway to an external statistical lab. The target institutional review board portal is browser-only, spreads the amendment across protocol summary, risk-change justification, consent-document uploads, external-collaborator disclosures, and investigator-attestation tabs, and final submission may proceed only after the principal investigator, privacy reviewer, and institutional research compliance office have all signed off in the study-governance system. Because a mistaken commit could authorize the wrong protocol version or expose sensitive participant-handling details, the workflow must recheck approvals, confirm the amendment packet still matches the approved protocol materials, and halt safely if the live portal, attachment state, or confirmation path becomes ambiguous. mermaid flowchart TD A["Recheck approvals and amendment packet"] B["Enter IRB portal amendment workflow"] C["Upload approved attachments"] D{"Ready to submit with matching portal state?"} E["Submit amendment in portal"] F["Halt at draft or abandon session"] G["Capture masked evidence and confirmation artifacts"] A --> B B --> C C --> D D --> E D --> F E --> G F --> G
Approved secondary-dataset access request triage packet for restricted governance review dispatch
A research data-governance team already has one evidence-backed triage packet assembled for a secondary dataset access request tied to a completed human-subjects study. Earlier monitoring already merged the request form, protocol-scope checks, consent-restriction flags, enclave-capability notes, prior duplicate submissions, and one recent sponsor-use clarification into a single bounded packet. The next step is not to decide whether the requester may receive access, reinterpret consent, negotiate conditions, publish findings, or activate any data movement; it is to decide whether that exact triaged packet revision may cross into the restricted governance review lane that handles sensitive secondary-use review. The workflow watches packet freshness, requester-role redaction, approval state, and lane-boundary rules, then releases the packet only when the named research-governance approver signs the dispatch manifest for that one downstream review queue. mermaid flowchart TD A["Exact triage packet awaiting restricted review dispatch"] B["Freshness and boundary checks packet revision, cited references, requester-role redaction, lane scope"] C{"All dispatch checks pass?"} D["Dispatch hold stale, superseded, mis-scoped, or insufficiently redacted packet"] E["Checks clear exact packet revision can enter approver review"] F["Research-governance approver review exact packet revision and dispatch manifest"] G["Dispatch remains blocked approval not yet signed for this revision and queue"] H["Approval signed exact packet revision authorized for queue release"] I["Restricted governance review queue exact approved packet revision dispatched"] A --> B B --> C C --> D C --> E E --> F F --> G F --> H H --> I
Benchmark claim-clarification packet approved for publication integrity review intake
An applied research lead, a reproducibility reviewer, and publication-operations partners are co-producing one governed claim-clarification packet because a benchmark paper draft now contains performance wording that must be reconciled with late reruns, hardware annotations, and external disclosure limits before integrity review. Agents help merge rerun tables, methodology caveats, reviewer objections, and approved claim wording into the shared packet while preserving which concerns remain contested and which edits the human artifact owner accepted. The workflow ends only when the named research release owner approves that exact packet revision for one bounded publication integrity review intake lane, where downstream reviewers may decide whether the claims are supportable or need further narrowing. It does not decide publication, submit the paper, or release benchmark artifacts externally. mermaid flowchart TD A["Collaborative claim-clarification packet revision"] B["Residual objections, caveats, and release boundaries stay visible"] C["Exact packet revision and release manifest prepared for approval"] D["Human research release owner approves integrity-review intake release"] E["Approved packet revision released into publication integrity review intake"] A --> B B --> C C --> D D --> E
Benchmark corpus lineage and version-of-record authoritative record reconciliation
After a benchmark corpus refresh is staged and storage metadata backfills land out of order, research platform governance discovers that the trusted version-of-record for one benchmark corpus no longer agrees across the benchmark registry, the corpus-lineage manifest store, the immutable object-snapshot index, and the governed benchmark control packet Benchmark-Corpus-Lineage-Reconciliation-Packet-v3. The registry still points benchmark atlasbench-fairness-suite to corpus revision corpus-r18, the lineage manifest records corpus-r19-candidate as the child revision derived from the same source snapshot plus an approved exclusion-list delta, and the object-snapshot index confirms most r19 shard hashes but still carries one active shard reference from r18. The prerequisite state is that corpus ingest is paused, the benchmark freeze tag is active, and all four control surfaces have been pinned into one read-only reconciliation window; the visible blockers are the unresolved shard-hash mismatch, the missing confirmation that the exclusion-list delta propagated to every shard, and the stale registry pointer embedded in Benchmark-Corpus-Lineage-Reconciliation-Packet-v3. Before any benchmark release, dataset rewrite, evaluation rerun, or downstream research execution continues, the workflow must restore one trusted corpus version-of-record, preserve explicit revision lineage, and stage a correction-ready packet for controlled record repair, with Benchmark Integrity Steward Leila Narang accountable for reconciliation quality only. mermaid flowchart TD start["Corpus version-of-record discrepancy found across benchmark registry, lineage manifest store, object-snapshot index, and packet v3"] --> gather["Gather pinned current records for the affected benchmark corpus and freeze window"] gather --> compare["Compare registry pointer, parent-child revision lineage, shard hashes, exclusion-list delta, and packet references under source precedence rules"] compare --> align{"Do consequential lineage and version-of-record fields align within approved precedence and freshness rules?"} align -->|"Yes"| ledger["Assemble one authoritative current-state benchmark corpus ledger with revision lineage"] align -->|"No"| hold["Keep packet v3 on explicit reconciliation hold with visible blockers and unresolved lineage gaps"] hold --> ledger ledger --> package["Stage Benchmark-Corpus-Lineage- Reconciliation-Packet-v3 with allowed write targets, rollback references, and discrepancy details"] package --> verify["Verify the trusted version-of-record is now reflected across the registry, lineage store, snapshot index, and governed packet"] verify --> stop["Bounded stop before benchmark release, dataset rewrite, evaluation rerun, or downstream research execution"]
Benchmark disclosure-control playbook change digest for research governance briefing
A research governance program maintains an approved benchmark disclosure-control playbook covering small-cell suppression thresholds, qualitative claim-framing limits, benchmark artifact labeling rules, approved replication-evidence references, exception-handling steps, and reviewer briefing checkpoints used before benchmark materials are discussed with internal publication and policy stakeholders. When that playbook is revised, research-governance leads need one bounded digest artifact, Benchmark-Disclosure-Control-Change-Brief-r4, that explains what changed in the newly approved playbook, which surrounding benchmark-governance context still applies from the prior baseline and standing control set, and which unresolved questions remain visible before the next governance briefing. The workflow must stop at informational handoff for research-governance briefing; it must not recommend publication go/no-go, adjudicate exceptions, coordinate collaborators, investigate why the playbook changed, or execute any live disclosure or release action. mermaid flowchart TD A["Approved disclosure-control playbook revision event"] B["Compare revised playbook against prior approved baseline"] C["Assemble bounded governance context from taxonomy, checklist, and exceptions"] D["Separate unresolved mapping or policy-interpretation questions"] E["Publish governed digest artifact Benchmark-Disclosure-Control-Change-Brief-r4"] A --> B B --> C C --> D C --> E D --> E
Benchmark evaluation environment inconsistency anomaly review
A research evaluation governance team monitors scheduled benchmark reruns, environment manifests, container digests, accelerator assignments, tokenizer and runtime versions, queue-worker placement, and reviewer notes to detect mid-severity evaluation-environment anomalies before they harden into a formal reproducibility incident or publication-integrity escalation. The workflow must collapse duplicate anomalies tied to the same study, benchmark suite, and review window; enrich each case with the approved evaluation baseline, planned infrastructure changes, environment provenance gaps, prior reviewer dispositions, and claim sensitivity; and then prioritize which unexplained inconsistencies deserve human review. A case should enter the review queue when, for example, nominally identical benchmark runs alternate between two accelerator classes without an approved migration note, the same prompt cohort is evaluated under mismatched tokenizer or runtime hashes during a release-sensitive review window, or evaluation jobs spill across regions with different container digests even though the study manifest still records one canonical environment. The goal is an explainable anomaly review packet for research governance, benchmark platform owners, or reproducibility reviewers, not to authorize reruns, diagnose root cause, reconfigure infrastructure, or decide publication posture automatically. mermaid flowchart TD A["Anomaly signal ingestion Run manifests, environment provenance, placement, and reviewer notes"] B["Duplicate merge Collapse cases by study, benchmark suite, and review window"] C["Baseline/context enrichment Attach approved baseline, change records, provenance gaps, prior dispositions, and claim sensitivity"] D["Prioritization Rank unexplained inconsistencies by impact, confidence, and review urgency"] E["Human review routing Send explainable packet to research governance, benchmark platform owners, or reproducibility reviewers"] A --> B B --> C C --> D D --> E
Benchmark-evaluation exception and evidence-gap board shared workbench upkeep
An internal benchmark governance group maintains one governed internal artifact, Benchmark-Evaluation-Exception-Evidence-Gap-Board-v4, while benchmark owners, reproducibility reviewers, methods stewards, and platform evaluators continuously refine notes attached to evaluation exceptions and missing support evidence across a shared model-benchmark program. Each row already carries prerequisite state: the benchmark suite id, exception ticket id, affected run-set reference, current evaluation-window tag, latest evidence-link bundle, accepted row owner, explicit blocker fields, unresolved comparability tags, and revision-aware lineage from v2 and v3 into v4. As small updates arrive, the agent keeps that bounded workbench synchronized by applying explicit source precedence from the approved benchmark-evaluation standard and exception-handling rules before frozen run manifests, benchmark registry snapshots, environment attestations, and reviewer annotations, refreshing source links, normalizing duplicate evidence-gap notes, preserving accepted hold-state markers, and carrying unresolved benchmark-scope, comparability, or evidence-freshness conflicts forward in a visible register. Humans remain responsible for deciding whether an exception is valid, whether the available evidence is sufficient, whether a benchmark result is still comparable, whether any rerun or disclosure note is required, whether publication or recommendation work should begin, and whether any downstream benchmark execution or reviewer assignment should occur. mermaid flowchart TD A["Approved benchmark-evaluation standard and exception-handling rules"] E["Frozen run manifests, benchmark registry snapshots, and environment attestations"] R["Reviewer annotation and methods-note surface"] B["Benchmark-evaluation exception and evidence-gap board v4"] G["Agent upkeep pass applies source precedence"] H["Visible register open blockers and unresolved gaps"] M["Benchmark governance steward or named row owner review"] S["Stop and hand off to adjacent workflow if update requires reviewer assignment, exception adjudication, publication drafting, recommendation, rerun approval, or downstream execution"] A -->|"Authoritative benchmark and exception rules first"| G E -->|"Refresh run links, evidence timestamps, and environment provenance"| G R -->|"Gap notes, comparability comments, and ownership updates"| G B -->|"Prior board state and lineage"| G G -->|"Refresh references, normalize duplicates, preserve owners and hold markers"| B G -->|"Carry unresolved items forward"| H H -->|"Human follow-up on open blockers"| M G -->|"Boundary-triggering update"| S
Benchmark metadata hygiene watchlist upkeep
A research methods stewardship team monitors recurring low-severity benchmark metadata hygiene signals across internal study catalogs, experiment registries, and result dashboards: missing annotation fields, stale dataset-card references, repeated absent reviewer tags, inconsistent benchmark-suite labels, and minor documentation gaps that do not yet call benchmark validity into question. The workflow must merge duplicate signals by study portfolio, benchmark suite, and review window, enrich each watchlist item with study owner, upcoming review cadence, prior deferments, and recent healthy metadata checks, and then publish a routine upkeep queue for methods stewards and study coordinators. The goal is to keep small but persistent metadata gaps visible before they mature into publication-readiness, disclosure, or integrity-review concerns, not to challenge study claims, block sharing, or launch a root-cause investigation automatically. mermaid flowchart TD A["Recurring benchmark metadata hygiene signals across catalogs, registries, and dashboards"] B["Merge recurring signals by study portfolio, benchmark suite, and review window"] C["Enrich bounded watchlist context with study owner, review cadence, deferments, and healthy checks"] D["Publish routine metadata hygiene watchlist and upkeep queue for stewards"] E["Trigger escalation when recurrence age or scope exceeds delegated watchlist limits"] A --> B B --> C C --> D C --> E
Benchmark portfolio bundle retuning
A research operations lead oversees a shared benchmark-program tuning bundle that influences multiple coupled surfaces: study intake scoring, replication-review sensitivity, documentation-sufficiency weighting, and publication-readiness prioritization for a portfolio of model benchmark studies. Recent outcome history shows that the current bundle favors novelty and short review-cycle completion, but replication-review overrides, disclosure-risk rechecks, and late-stage documentation repairs are rising for studies with weaker reproducibility evidence or more complex data-use constraints. The workflow must produce a governed retuning package that adjusts the shared bundle so reproducibility quality, disclosure integrity, and review stability improve together, without letting the system decide whether a study may publish, rewrite research policy, or trigger downstream release actions on its own. mermaid flowchart TD A["Outcome analysis consolidates override clusters, disclosure-risk rechecks, documentation repairs, and active benchmark-bundle behavior across coupled review surfaces"] B["Protected-parameter and evidence checks confirm reproducibility floors, disclosure-integrity limits, fairness constraints, and policy-linked tuning boundaries"] C["Replay workspace tests candidate bundle versions against prior benchmark-study cohorts for intake scoring, replication sensitivity, documentation weighting, and readiness prioritization"] D["Governed retuning package compares cross-surface winners and losers, candidate bundle versions, deferred policy-adjacent moves, and rollback triggers before any adoption choice"] E{"Do research stewards accept the trade-offs and adopt the candidate bundle with an explicit rollback boundary?"} F["Keep the prior trusted bundle active, record why adoption was deferred or rejected, and preserve the rollback-ready boundary"] G["Human-adopted candidate bundle is approved at the boundary with trade-off visibility, deferred changes, and rollback conditions carried forward"] A --> B B --> C C --> D D --> E E --> F E --> G
Benchmark replication-review scoring revision approved for live use
A research integrity lead has prepared one exact replication-review scoring revision for a benchmark publication program after replay shows that the current live profile underweights cross-lab divergence, dataset-governance caveats, and disclosure-sensitive benchmark claims during final review. The candidate revision increases sensitivity to rerun instability, tightens protected integrity floors for governance-heavy datasets, and defines a restore target if false-positive burden or missed replication risk rises. The workflow must release that exact scoring revision into bounded live use only after a human approver confirms the manifest, validity window, and rollback packet, while staying bounded at optimization-state release rather than deciding publication readiness, revising benchmark claims, or releasing study artifacts externally. mermaid flowchart TD A["Prepare exact replication-review scoring revision candidate"] B["Verify replay evidence, revision hash, benchmark-program scope, and restore target"] C{"Manifest, validity window, and rollback packet complete?"} D["Hold release until verification gaps or packet errors are corrected"] E{"Named approver authorizes that exact revision for bounded live use?"} F["Activate approved scoring revision for the named benchmark publication program and write audit trace"] G{"False-positive burden, missed replication risk, or validity-window expiry triggered?"} H["Keep revision live within the approved benchmark-program window"] I["Restore the prior trusted scoring profile and record rollback or expiry action"] A --> B B --> C C -->|"No"| D C -->|"Yes"| E E -->|"No"| D E -->|"Yes"| F F --> G G -->|"No"| H H -->|"Within window"| G G -->|"Yes"| I
Benchmark study artifact freeze completion verification
A benchmark-study owner records that the study's artifact freeze is complete after uploading the final evaluation outputs, manifests, and supporting notebooks for an internal governance review. Governance coordinators still need to confirm whether that claimed freeze state is actually supported by the approved artifact registry, immutable object-store manifest, and review-packet references before they rely on the study as fixed-input evidence. The workflow verifies the claim against those authoritative sources and emits a bounded verdict; it must not approve the study, reopen the evidence packet, or decide any publication or review outcome. mermaid flowchart TD A["Freeze-complete claim recorded"] B["Check artifact registry freeze status and inventory"] C["Check immutable manifest hashes and retention markers"] D["Check review-packet artifact and manifest references"] E["Evaluate corroborating evidence against the claim"] F["Confirmed freeze state"] G["Disproved freeze state"] H["Inconclusive freeze state"] A --> B A --> C A --> D B --> E C --> E D --> E E --> F E --> G E --> H
Benchmark study artifact-freeze readiness gate disposition recommendation
A research governance panel is reassessing whether a benchmark study can pass its artifact-freeze gate before an external workshop submission deadline. Since the previous check, one reproducibility rerun succeeded, a license clarification for a third-party evaluation corpus remains unresolved, and a late privacy review note requires narrowing one prompt subset unless additional redaction evidence arrives. The workflow must recommend whether research should proceed with the package as scoped, hold the gate, narrow the submission to the fully cleared workload set, or escalate because reproducibility, disclosure, or dataset-rights thresholds now sit outside delegated publication-gate authority before any external artifact is finalized. mermaid flowchart TD A["Refresh benchmark-study artifact-freeze gate evidence with the latest reproducibility, rights, and privacy signals"] B["Review rerun success, dataset-rights clarification, prompt-subset privacy scope, and delegated publication-gate thresholds"] C{"All required gate evidence is current and within delegated authority for the full study package?"} D{"A narrower cleared workload set and prompt scope can pass without unresolved blocker spillover?"} E{"Remaining issues are refreshable blockers that still stay within local gate-control limits?"} P["Recommend proceed as scoped for the current artifact-freeze package"] N["Recommend narrow to the cleared workload set and approved prompt subset"] H["Recommend hold for refreshed rights, privacy, or reproducibility evidence"] X["Recommend escalate because threshold or authority limits are exceeded"] J["Hand off the disposition packet, blocker register, and rationale to the research governance panel"] A --> B B --> C C -->|"Yes"| P C -->|"No"| D D -->|"Yes"| N D -->|"No"| E E -->|"Yes"| H E -->|"No"| X P --> J N --> J H --> J X --> J
Benchmark study artifact packet to research review intake record handoff
An applied research enablement team receives a submission packet from an internal multimodal-model benchmarking squad that wants a new study entered into the organization's pre-publication review pipeline. The packet combines a draft extended abstract, experiment tracker exports, evaluation notebook snapshots, dataset licensing notes, annotator-guideline excerpts, a model card draft, red-team observation summaries, and a spreadsheet of headline benchmark numbers prepared for a possible workshop submission. Before any publication decision, external abstract submission, leaderboard update, or executive circulation occurs, the workflow must transform that heterogeneous packet into a structured research-review intake record with required fields for study owner, benchmark question, candidate title, model variants, dataset and prompt-set versions, evaluation window, metric definitions, compute environment, artifact inventory, privacy and licensing flags, uncertainty notes, and source-evidence links while preserving contradictions and missing details. mermaid flowchart TD A["Benchmark study artifact packet intake"] B["Field extraction from draft, tracker, notebook, and table artifacts"] C["Normalization to intake schema, controlled metadata, and source links"] D{"Required fields, provenance, and policy checks pass?"} E["Exception routing for privacy, licensing, reproducibility, or conflicts"] F["Structured research-review intake record handoff"] A --> B B --> C C --> D D -->|"No"| E D -->|"Yes"| F
Benchmark study disclosure risk alert triage
A research governance team monitors a continuous stream of disclosure-risk signals around active benchmark studies, including draft-paper sharing events, slide-deck exports, embargo milestones, reproducibility regression alerts, dataset-rights changes, external-review requests, and publication-policy exceptions. The workflow must collapse duplicate signals tied to the same study, claim set, or disclosure window; enrich each alert with benchmark scope, artifact sensitivity, prior reviewer concerns, partner or vendor restrictions, and current embargo posture; and then prioritize which cases need immediate human review. A case should rise to the urgent queue when, for example, an externally shareable draft still depends on a newly failed replication, a dataset license changes after benchmark figures were circulated for review, or multiple external-access requests arrive near an embargo boundary for a study with unresolved disclosure caveats. The goal is to create an evidence-backed triage packet for research governance, publication-review, or legal-and-communications reviewers, not to decide publication posture, rewrite the benchmark claims, grant artifact access, or run a retrospective investigation. mermaid flowchart TD A["Disclosure-risk alert stream"] B["Merged alert cluster by study, claim set, or disclosure window"] C["Policy context enrichment benchmark scope, sensitivity, restrictions, embargo posture"] D["Prioritized triage packet severity, rationale, queue placement"] E["Human-routed escalation research governance, publication review, legal and communications"] A --> B B --> C C --> D D --> E
Benchmark-study disclosure-risk triage packet approved for restricted disclosure-governance review dispatch
A research governance team already has an evidence-backed disclosure-risk triage packet assembled for one benchmark study after earlier monitoring merged draft-sharing telemetry, a late rerun regression, a dataset-rights change, and an outside-review request against the same embargo window. The next step is not to decide whether external reviewers may see the draft, narrow the benchmark claims, notify partners, or approve publication; it is to decide whether the exact packet revision may cross into the restricted disclosure-governance review lane that can trigger those downstream human workflows. The dispatch workflow watches packet freshness, annex redaction state, signer approval, and bounded reviewer-audience rules, then releases the triaged packet only when the approved research-governance reviewer signs the dispatch manifest for that lane. mermaid flowchart TD packet["Approved disclosure-risk triage packet revision queued"] freshness["Packet freshness and evidence window check"] redaction["Annex redaction scope check"] signer["Research-governance signer approval check"] audience["Restricted reviewer audience boundary check"] hold["Dispatch hold register for stale, unredacted, unsigned, or out-of-bound packets"] manifest["Dispatch manifest bound to exact packet revision"] lane["Restricted disclosure-governance review lane dispatch"] packet --> freshness freshness --> redaction freshness --> hold redaction --> signer redaction --> hold signer --> audience signer --> hold audience --> manifest audience --> hold manifest --> lane
Benchmark study metric drift anomaly review
A research governance team monitors benchmark reruns, experiment metadata, artifact provenance checks, dataset-version changes, and reviewer comments to detect mid-severity metric-drift anomalies before they become publication, disclosure, or integrity incidents. The workflow must collapse duplicate anomalies tied to the same study, benchmark slice, and release window; enrich each case with expected variance bands, planned methodological changes, artifact lineage, prior reviewer notes, and claim sensitivity; and then prioritize which unexplained drifts deserve human review. A case should enter the review queue when, for example, a headline benchmark score jumps beyond the approved variance band without a matching study-plan update, repeated reruns disagree because one artifact lineage is incomplete, or a dataset-version change coincides with unexplained subgroup drift in a study slated for near-term sharing. The goal is an explainable anomaly review packet for benchmark governance, study owners, or research-integrity reviewers, not to decide publication posture, retract claims, run a root-cause analysis, or notify outside parties automatically. mermaid flowchart TD A["Drift signal detection Benchmark reruns, metric deltas, and provenance alerts"] B["Duplicate merge Collapse anomalies by study, slice, and release window"] C["Variance enrichment Attach approved variance bands and planned study changes"] D["Lineage enrichment Attach artifact lineage, dataset versions, and reviewer notes"] E["Prioritization Rank unexplained drift by claim sensitivity and review urgency"] F["Review routing Send the packet to the governed human review queue"] A --> B B --> C B --> D C --> E D --> E E --> F
Benchmark study publication go/no-go recommendation
A research governance review group is evaluating whether to support external publication of an internal benchmark study comparing model-serving platforms for enterprise generative-AI workloads. The study team wants to submit a workshop paper, brief product leadership, and publish a blog-ready summary before a major industry event, but the evidence packet still includes unresolved reproducibility gaps for one workload, a dataset-license ambiguity around a third-party corpus, and vendor-sensitivity concerns because one platform required nonstandard tuning to reach the reported result. The workflow must recommend whether research should support publication as scoped, narrow the publication package to safer claims and approved artifacts, or escalate because reproducibility, licensing, privacy, or reputational-risk thresholds move outside delegated approval limits before any abstract, briefing, or public claim is committed. mermaid flowchart TD A["Assemble benchmark publication evidence packet and governing publication policy inputs"] B["Review reproducibility gaps, dataset-license ambiguity, vendor-sensitivity concerns, and approval thresholds"] C{"Evidence and policy review support publication as currently scoped?"} D{"A narrower package with safer claims and approved artifacts stays within policy?"} E["Recommend support publication as scoped"] F["Recommend narrow to safer claims and approved artifacts"] G["Recommend escalate for higher publication, legal, or communications review"] H["Hand off the recommendation packet, caveats, and evidence links to the research governance review group"] A --> B B --> C C -->|"Yes"| E C -->|"No"| D D -->|"Yes"| F D -->|"No"| G E --> H F --> H G --> H
Benchmark study publication-integrity intake packet approved for restricted review lane
A research publication-operations team is preparing one bounded publication-integrity intake packet for a benchmark study that may eventually support a workshop paper and controlled public artifact release. The authoritative source state spans the benchmark claim register, experiment rerun manifests, dataset-rights clearances, disclosure-review notes, approved abstract metadata, redaction and embargo flags, and prior packet hold history. The downstream restricted lane expects one transformed packet with normalized study and claim identifiers, evidence-lineage references, rights and disclosure tags, held-field markers, and an approval manifest authorizing handoff into that single publication-integrity review intake queue. The workflow must stop once that exact packet revision is approved for intake, without collaboratively redrafting the manuscript, recommending whether the study should be published, adjudicating claim support, submitting the paper, or disclosing benchmark artifacts externally. mermaid flowchart TD source["Authoritative benchmark source state claim register, rerun manifests, rights clearances disclosure notes, metadata, flags, and hold history"] transform["Transform one intake packet revision normalize study and claim identifiers preserve lineage, rights tags, and held-field markers"] hold["Hold handling register capture stale lineage, rights conflicts scope mismatches, and identifier mismatches"] manifest["Approval manifest assembly bind exact packet revision, restricted lane signers, held annexes, and audience scope"] approve["Research publication-governance approval review exact packet version and manifest for restricted intake release"] release["Restricted intake release handoff approved packet only to the publication-integrity review queue"] source --> transform transform --> hold hold --> transform transform --> manifest manifest --> approve approve --> release
Benchmark study publication-readiness review scheduling
An applied research program manager needs to schedule a publication-readiness review for an internal benchmark study before the team can submit a workshop abstract and circulate the headline results to product leadership. The meeting must include the study lead, the reproducibility reviewer, the privacy reviewer, the dataset licensing owner, and the research communications partner because the review sits inside a five-business-day embargo window between final result freeze and external abstract submission. The workflow is about constructing a viable slot across San Francisco, New York, and London calendars, placing reversible holds, and escalating quickly when no in-policy overlap exists rather than guessing at attendee substitutions, relaxing the embargo window, or making the final meeting commitment without human confirmation. mermaid flowchart TD A["Scheduling request within the allowed review window"] B["Gather required roles and time constraints"] C["Collect free-busy, timezone, and working-hour limits"] D["Find a viable slot that covers required attendees"] E["Place tentative holds on the best viable slot"] F["Escalate when no in-policy slot or no acceptable overlap exists"] G["Human confirms the selected slot before the invite becomes final"] A --> B B --> C C --> D D --> E D --> F E --> G
Benchmark study publication recommendation packet revision approved for publication council decision lane
A research publication workflow has already prepared one exact recommendation packet revision for an external benchmark-study release. The packet narrows the bounded options to publish the workshop paper and approved abstract as scoped, narrow the release to the cleared workload set and claim bundle, or escalate to chief research and legal review, and it keeps blocked paths such as a broader vendor-comparison blog post or public artifact release before rights clearance explicit. Before that exact packet revision can enter the restricted publication council decision lane, a named research release owner must approve the council scope, embargo window, and manifest binding so reviewers receive the governed recommendation artifact rather than a stale or broadened copy. The workflow stops at governed release of that packet revision; it does not decide whether publication proceeds, submit the paper, or disclose the benchmark externally. mermaid flowchart TD ready["Exact benchmark-study publication recommendation packet revision ready"] verify["Verify packet hash, bounded publication options, and blocked paths against current revision"] scope["Confirm publication council lane, embargo window, and manifest binding remain in scope"] approve["Named research release owner reviews approval or hold state"] hold["Hold packet revision for manual follow-up, manifest correction, or supersession"] release["Release exact packet revision to publication council lane with publish, narrow, or escalate options"] record["Record manifest-bound handoff and block forwarding outside approved publication council audience"] ready --> verify verify --> scope verify --> hold scope --> approve scope --> hold approve --> release approve --> hold release --> record
Benchmark study publication timeline replanning after evidence-analysis or clearance delay
An applied research program already has an internal benchmark-study publication timeline that sequences final evidence analysis, reproducibility review, data-governance clearance, publication-readiness review, abstract lock, and the external submission deadline. Then the baseline plan stops being feasible: a late evidence-analysis rerun delays one benchmark claim package, or data-governance clearance for a training-data subset takes longer than expected, compressing the original publication-review window and threatening the abstract submission path. The workflow should recompute a revised timeline, document which milestones can move or must stay fixed, and prepare a coordination-ready replanning packet for the study lead, governance coordinator, reproducibility reviewer, and communications partner rather than deciding whether review steps may be skipped, adjudicating publication integrity, or submitting anything externally. mermaid flowchart TD A["Delay detected in evidence analysis or clearance"] B["Collect updated milestone, reviewer, and clearance status"] C["Recompute feasible publication timeline options"] D{"Any in-policy timeline preserves required review steps and the fixed deadline?"} E["Build revised publication timeline"] F["Record moved milestones, fixed checkpoints, and residual risks"] G["Assemble coordination-ready replanning packet"] H["Study lead, governance coordinator, and reviewers review the revised plan"] I["Prepare exception-focused replanning packet with blockers and unmet constraints"] A -->|"Refresh dependency state"| B B -->|"Test hard constraints"| C C -->|"Check policy-safe path"| D D -->|"Yes"| E E -->|"Document impacts"| F F -->|"Prepare handoff"| G G -->|"Route for adoption"| H D -->|"No"| I I -->|"Escalate for human decision"| H
Benchmark study research review intake record refresh after rerun manifest update
An applied research governance program already maintains a staged research-review intake record for an in-flight benchmark study so reproducibility, privacy, and publication-operations reviewers can inspect one current structured packet instead of reopening the experiment tracker, artifact registry, dataset notes, methods annexes, and prior intake exceptions every time source state changes. After that intake record is issued, authoritative updates still arrive: a signed rerun manifest supersedes a draft benchmark results bundle, a methods annex corrects hardware configuration notes, a dataset-version registry entry narrows which prompt-set release is in scope, or exception lineage is updated to show that one previously cited score table was withdrawn. Each approved source change should trigger refresh of the staged research-review intake record, preserving field-level delta lineage, explicit current-versus-superseded values, and exception routing whenever conflicting rerun provenance, unresolved dataset-version drift, or policy-disallowed overwrite logic would make the refreshed packet unsafe for downstream restricted review. mermaid flowchart TD A["Approved source change"] B["Current authoritative source bundle"] C["Prior staged intake record baseline"] D["Staged intake record refresh"] E["Delta lineage and supersession trace"] F["Current refreshed staged intake record"] G["Exception routing queue"] A --> B A --> C B --> D C --> D D --> E D --> F D --> G
Biorepository freezer-failure specimen-preservation continuity activation gate
After a freezer failure or freezer-monitoring failure is declared for one governed biorepository storage pod, biorepository continuity leadership has already identified the bounded fallback path and the accountable approval owner: a governed biospecimen-preservation continuity packet for controlled transfer into prequalified backup ultra-low or vapor-phase storage if the primary storage envelope cannot be trusted before specimen stability windows are exhausted. Upstream truth-restoration and authority-routing work has already established the trusted affected freezer scope, authoritative specimen inventory and rack map, specimen-priority cohorts, validated backup-capacity ledger, and approval lane, with validated laboratory information management system inventory, calibrated sensor history, and qualified backup-capacity records explicitly outranking handwritten shelf notes, local whiteboards, or informal message-thread updates. The planning workflow now has to prepare one activation-ready packet showing backup storage qualification state, dry-ice or liquid-nitrogen reserve readiness, retrieval-team and witness coverage, specimen-class handling rules, custody-form packet version, and exposure-timer controls. It should preserve explicit holds for any unresolved box-location mismatch, missing backup-capacity reservation, unqualified transport vessel, stale consent or material-transfer restriction mapping, unreadable label cohort, or packet-version lineage gap, and stop at the approval gate rather than selecting the authority lane, sending sponsor or campus communications, moving specimens, executing custody transfers, rescheduling assays, or performing downstream continuity actions. mermaid flowchart TD A["Declared freezer-failure or monitoring-failure scope, authoritative specimen inventory, and approval lane received"] --> B{"Validated inventory, sensor history, and backup-capacity references still match accepted authoritative sources?"} B -->|"No"| H["Escalate bounded mismatch for stale inventory scope, conflicting telemetry, or unclear activation prerequisites"] B -->|"Yes"| C{"Backup storage qualification, retrieval-team coverage, and exposure-timer controls verified?"} C -->|"No"| G["Keep the packet on hold with explicit capacity, staffing, or specimen-handling blockers"] C -->|"Yes"| D{"Custody-form packet version, specimen-use restrictions, and transport-vessel readiness fully represented?"} D -->|"No"| G D -->|"Yes"| E["Assemble the activation-ready packet, readiness ledger, and hold register"] E --> F{"Named biorepository continuity owner approves the specimen-preservation packet?"} F -->|"No"| G F -->|"Yes"| I["Record the approved packet and stop at the activation gate without moving specimens or executing custody"]
BSL-3 cryostorage excursion supervised specimen containment task orchestration
A biosafety lead is directing live containment work after a monitored cryostorage unit holding BSL-3 study specimens begins drifting above its approved temperature envelope during an overnight compressor failure. The agent may execute only the consequential steps the lead names: place specific specimen racks and downstream assay pulls on access hold, collect confirmation readings from the primary sensor and an independent probe, move named boxes into one qualified backup unit, update chain-of-custody and freezer-capacity records, and verify that each directed move preserved specimen identity, containment controls, and temperature recovery before continuing. Because the next safe action depends on what the last move actually changed and because the workflow must not infer a salvage plan, release specimens, or reinterpret biosafety policy on its own, it needs one authoritative step ledger, mandatory post-step verification, and a takeover-safe handoff if the lead transfers control to facilities engineering or institutional biosafety oversight. mermaid flowchart TD start["Biosafety lead names the next\nconsequential containment step"] --> state["Hydrate current freezer alarm state,\nqualified backup capacity,\nspecimen custody status,\nand pending assay pulls"] state --> scope{"Directed step still explicit and\ninside approved containment authority?"} scope -->|"Yes"| act["Execute one directed action:\nplace access hold, collect probe check,\nmove named boxes, or update custody records"] scope -->|"No"| hold["Hold execution, preserve current state,\nand package takeover context"] act --> verify{"Authoritative systems verify\ntemperature, location, identity,\nand containment state?"} verify -->|"Yes"| ledger["Record the human instruction,\nexecuted action, evidence,\nand verified current state"] verify -->|"No"| hold ledger --> next{"Biosafety lead directs another\nbounded live step?"} next -->|"Yes"| state next -->|"Escalate branch"| handoff["Prepare takeover packet for\nfacilities engineering or\ninstitutional biosafety oversight"] next -->|"No"| wait["Pause on verified current state\nwithout inferring the next move"] hold --> handoff
BSL-3 containment integrity multi-signal critical corroboration triage
A biosafety operations monitoring workflow watches for severe containment-integrity signals at a BSL-3 research facility running active select-agent studies: sustained pressure-differential failures reported by the building-management system in one suite, HEPA exhaust-filter resistance spikes that may indicate bypass or saturation events, airlock interlock faults logged by the access-control and egress-monitoring system, personnel decontamination shower usage recorded without a matching entry or egress event in the suite register, specimen chain-of-custody gaps where primary container check-ins are missing across two adjacent laboratories, and independent ad hoc incident reports filed separately by a research associate and a biosafety officer from different sections of the same corridor. The workflow must determine whether these signals corroborate one potentially critical containment-integrity breach affecting a common suite or egress path, preserve duplicate-aware linkage across subsystem alarms and overlapping incident filings, assemble an escalation packet with the linked evidence and unresolved uncertainty, and route that packet into a human-controlled biosafety safety command lane. It stops before any containment action selection, physical response dispatch, personnel outreach, experiment suspension, regulatory notification, or root-cause investigation. mermaid flowchart TD A["Severe pressure, HEPA, airlock, decontamination, chain-of-custody, and incident-report signals arrive across suite subsystems and lab sections"] --> B["Corroborate against suite-pressure topology, HEPA service and baseline history, airlock access and egress logs, decontamination records, specimen custody timeline, and prior incident-report lineage"] B --> C{"Independent evidence sources support one credible critical containment-integrity event?"} C -->|"No"| D["Keep in severe triage queue with unresolved-corroboration notes"] C -->|"Yes"| E{"Critical-threshold policy met for human biosafety command escalation?"} E -->|"No"| F["Maintain elevated watch state with explainable priority and case linkage"] E -->|"Yes"| G{"Existing critical case or duplicate cluster already covers this containment-breach pattern?"} G -->|"Yes"| H["Merge lineage into active critical case and refresh the reviewer packet"] G -->|"No"| I["Assemble critical escalation packet with linked signals, suite scope, and uncertainty"] H --> J["Route corroborated packet update to the human-controlled biosafety command lane"] I --> J
Clinical trial emergency unblinding manual continuity activation gate
After an interactive randomization and treatment-allocation service outage is declared, clinical research safety governance has already identified the bounded fallback path and the accountable approval owner: a manual emergency unblinding continuity path for one active blinded study where participant-safety decisions may require access to treatment assignment before the primary service recovers. Upstream truth-restoration and authority-routing work has already established the trusted outage scope, affected protocol cohort, sealed code-list custody references, and approval lane. The planning workflow now has to prepare one activation-ready packet showing sealed-code custody, on-call medical monitor and unblinding pharmacist coverage, participant-identity crosswalk controls, protocol-specific eligibility checks, and audit-trail readiness for any emergency request. It should preserve explicit holds for any broken code-list custody chain, uncovered dual-review shift, stale participant crosswalk, unresolved protocol-specific unblinding condition, or sponsor-safety sign-off ambiguity, and stop at the approval gate rather than unblinding any participant, notifying sites, updating study records, or changing treatment conduct. mermaid flowchart TD A["Declared randomization-service outage scope, affected blinded protocol cohort, and approval lane received"] --> B{"Trusted outage references, sealed code-list custody, and approval lane still match accepted sources?"} B -->|"No"| H["Escalate bounded mismatch for stale custody references or unclear activation prerequisites"] B -->|"Yes"| C{"Medical monitor coverage, unblinding pharmacist availability, and participant-identity crosswalk controls verified?"} C -->|"No"| G["Keep the packet on hold with explicit staffing, custody, or identity-linkage blockers"] C -->|"Yes"| D{"Protocol-specific eligibility checks, audit-trail readiness, and sponsor-safety constraints fully represented?"} D -->|"No"| G D -->|"Yes"| E["Assemble the activation-ready packet, readiness ledger, and hold register"] E --> F{"Named clinical research safety approval owner approves the emergency-unblinding continuity packet?"} F -->|"No"| G F -->|"Yes"| I["Record the approved packet and stop at the activation gate without unblinding participants or changing study conduct"]
Controlled cohort small-cell suppression clarification packet approved for restricted data-governance review intake
A research data steward, a statistical disclosure-control lead, and a manuscript operations partner are co-producing one governed controlled cohort small-cell suppression clarification packet because a manuscript-ready supplementary table set and companion cohort summary export now contain low-count slices, linked geography fields, and exception requests that may exceed the institution's approved disclosure boundary for controlled research data. Agents help reconcile table drafts, suppression-rule annotations, investigator objections, repository restrictions, and approved clarification wording into the shared packet while preserving which cells remain disputed, which utility-preserving exceptions exceed the approved disclosure threshold, which cohort-linkage caveats stay unresolved, and which residual caveats the human artifact owner accepted explicitly. The workflow ends only when the named research release owner approves that exact packet revision and its release manifest for one restricted data-governance review intake lane, where downstream reviewers may decide whether the packet is sufficient for formal controlled-data disclosure review or needs narrower table content and refreshed de-identification treatment. It does not adjudicate disclosure acceptability, provision the dataset, communicate with outside researchers or journals, submit supplementary materials, or decide the downstream review outcome. mermaid flowchart TD A["Collaborative small-cell suppression clarification packet revision"] B["Unresolved suppression objections, linkage caveats, and release boundaries stay visible"] C["Exact packet revision and release manifest prepared for approval"] D["Human research release owner approves restricted data-governance intake release"] E["Approved packet revision released into restricted data-governance review intake"] A --> B B --> C C --> D D --> E
Cross-lab benchmark replication discrepancy investigation
Ahead of an internal model-governance review, a second evaluation team cannot reproduce a headline benchmark gain from a multimodal retrieval study comparing two model-serving configurations. The discrepancy could stem from dataset snapshot drift after a late redaction refresh, an evaluation-harness tokenizer change, a retrieval index built from a newer document corpus than the study packet recorded, or a silent serving fallback that routed the original run to a larger checkpoint than the one documented in the benchmark summary. The workflow reconciles experiment metadata, dataset lineage, artifact hashes, serving telemetry, and reviewer notes into a defensible explanation of why the results diverged, what remains uncertain, and which verification checks still require accountable human follow-through before anyone reuses, narrows, or withdraws the benchmark claim. mermaid flowchart TD A["Observed benchmark discrepancy between original and replication runs"] B["Reconcile experiment metadata, dataset lineage, artifact hashes, and serving telemetry"] C["Test hypothesis 1: dataset snapshot drift"] D["Test hypothesis 2: evaluation-harness tokenizer change"] E["Test hypothesis 3: newer retrieval index corpus"] F["Test hypothesis 4: silent serving fallback to larger checkpoint"] G["Compare supporting and disconfirming evidence across competing hypotheses"] H["Produce defensible explanation for the divergence"] I["Record residual uncertainty, missing artifacts, and pending verification checks"] A --> B B --> C B --> D B --> E B --> F C --> G D --> G E --> G F --> G G --> H G --> I H --> I
De-identified participant interview batch to release-safe study dataset
An applied research team is preparing a cross-site methods review for a study on how enterprise developers evaluate model-generated code suggestions during secure software delivery. The raw batch includes interview transcripts, moderator notes, consent-status exports, annotation worksheets, screen-capture excerpts, and follow-up participant emails that mention employer names, team structures, incident examples, internal tool names, and a few accidental disclosures about production environments. Before any methods board review, cross-lab sharing, or publication-readiness discussion can occur, the workflow must transform that sensitive batch into a release-safe structured study dataset with pseudonymous participant ids, coded topic spans, normalized study-phase labels, allowed demographic buckets, issue taxonomy tags, disclosure-risk flags, and evidence links that stay inside the restricted boundary while making remaining ambiguity and suppressed content visible to reviewers. mermaid flowchart TD intake["Sensitive batch intake transcripts notes consent exports screen captures"] transform["De-identification and coding pseudonymous ids coded spans normalized buckets taxonomy tags"] exception["Exception review residual disclosure consent conflict semantic-loss checks"] staging["Release-safe dataset staging review dataset transformation trace approval manifest"] intake --> transform transform --> exception transform --> staging exception --> staging
Embargoed benchmark artifact spot-check sampling-rate tuning
A research integrity team performs spot checks on benchmark-study artifacts, reproducibility packets, disclosure annexes, and claims tables before embargoed benchmark results are briefed to partners, leadership, or publication stakeholders. The fixed sampling policy has been efficient for routine internal studies, but recent findings show that lower-volume embargoed artifacts with rerun instability, disclosure-sensitive annexes, or negative-result replication disputes generate more meaningful review defects than the baseline sample captures. The workflow must autonomously retune bounded spot-check sampling rates so higher-risk artifact cohorts receive more oversight, while preserving protected floors for sensitive disclosure classes, keeping blinded or conflict-managed information contained, respecting reviewer-capacity limits, and rolling back quickly if the loop starts overreacting to a small number of atypical defects. mermaid flowchart TD A["Cohort findings and capacity inputs Aggregate defect yield, escaped-issue signals, protected floors, cooldown status, and reviewer capacity"] B["Bounded evidence check Confirm stable evidence windows, sparse-signal thresholds, and embargo-safe cohort definitions before tuning"] C["Candidate sampling retune Propose bounded rate increases or decreases for artifact cohorts inside delegated step limits"] D{"Do proposed changes stay within protected floors, cooldown rules, and reviewer-capacity bounds?"} E["Apply tuned sampling policy Write the new version, supporting audit record, and explicit rollback triggers"] F["Freeze autonomous tuning Keep the prior trusted sampling policy active until research-integrity review completes"] G{"Do later audit signals show escaped issues or overreaction after the retune?"} H["Rollback to the last trusted policy Record the trigger, recovery action, and affected artifact cohorts"] A --> B B --> C C --> D D --> E D --> F E --> G G --> A G --> H
Embargoed benchmark replication review queue reprioritization
A central research-quality team manages a backlog of benchmark-study replication and validation packages before any externally visible paper, workshop submission, or leadership briefing can move forward. The queue mixes internal model-serving benchmarks, partner-funded evaluation studies, negative-result replications, and follow-up reviews triggered by earlier reproducibility defects. Recent outcome data shows that reviewers have been pulling forward polished submissions from well-resourced teams while packages with partial rerun failures, embargo-sensitive partner data, or statistically ambiguous negative findings sit longer and later require disruptive last-minute escalations. The optimization workflow must continuously retune queue order so studies with the highest external-claim risk, imminent embargo decisions, or reproducibility instability rise appropriately, while preserving fairness across teams, protecting blinded review norms where applicable, respecting finite reviewer capacity, and maintaining a fast rollback path if the feedback loop starts rewarding presentation quality over scientific risk. mermaid flowchart TD R["Risk inputs reproducibility instability embargo pressure"] F["Fairness inputs negative-result delay checks team-bias guardrails"] C["Capacity inputs reviewer load specialist availability"] T["Bounded queue retuning adjust weights within approved ranges"] P["Publish revised order updated ranked review queue study-level rationale"] B["Rollback boundary restore last trusted policy escalate retuning packet"] R --> T F --> T C --> T T --> P T --> B
Emergency unblinding and investigational product quarantine state truth restoration
During a high-consequence serious adverse event bridge for a blinded multicenter trial, sponsor oversight finds that current emergency-unblinding and investigational-product quarantine state has diverged across the interactive response technology system, the restricted emergency code-break ledger, site pharmacy accountability records, and the safety command workspace. One source shows a participant emergency unblinding request as completed with a treatment assignment viewed by an authorized clinician, another still shows the participant as blinded, and the linked kit identifiers appear quarantined in one pharmacy record but still available for dispense in another. At the same time, one site's overnight manual custody note references a replacement kit move that does not align cleanly with the central chain-of-custody timeline. Before sponsor medical, data-management, pharmacy, and trial-operations leaders decide whether the current state is stable enough for any downstream dosing hold, site instruction, protocol deviation review, or authority-facing action, the workflow must restore the trusted current state of participant blinding status, emergency code-break usage, linked kit quarantine state, and specimen or kit custody dependencies while keeping every unresolved truth gap on explicit hold. mermaid flowchart TD A["Critical discrepancy scope participant, code-break, kit, and custody window"] B["Source-precedence comparison IRT, restricted unblinding ledger, pharmacy, and safety workspace"] C["Resolved comparison set fresh evidence and lineage align for current-state acceptance"] D["Unresolved hold branch material conflict, stale evidence, or broken custody linkage remains visible"] E["Trusted current-state ledger accepted blinding, code-break, quarantine, and custody state"] F["Hold register explicit provisional branches and unresolved truth gaps"] G["Restricted handoff only ledger, holds, evidence lineage, and bounded reviewer package"] A --> B B --> C B --> D C --> E D --> F E --> G F --> G
High-consequence pathogen near-miss exposure triage packet approved for restricted biosafety oversight review dispatch
A research biosafety office already has one evidence-backed triage packet assembled for a near-miss exposure event involving a high-consequence pathogen study. Earlier monitoring already merged badge-access logs, cabinet alarm telemetry, specimen inventory references, training and fit-test records, duplicate incident notices from the principal investigator and lab manager, and one recent containment-engineering clarification into a single bounded packet. The next step is not to determine whether an exposure occurred, classify severity, notify regulators, initiate medical surveillance, suspend experiments, or direct lab operations; it is to decide whether that exact triaged packet revision may cross into the restricted biosafety oversight review lane that handles high-consequence containment incidents. The workflow watches packet freshness, annex minimization, approval state, and lane-boundary rules, then releases the packet only when the named biosafety approver signs the dispatch manifest for that one protected downstream review queue. mermaid flowchart TD packet["Near-miss exposure triage packet revision queued"] freshness["Packet freshness and cited-source check"] minimization["Annex minimization scope check"] signer["Named biosafety approver signoff check"] boundary["Restricted oversight review lane boundary check"] hold["Dispatch hold register for stale, over-broad, unsigned, or out-of-bound packets"] manifest["Dispatch manifest bound to exact packet revision"] lane["Restricted biosafety oversight review dispatch"] packet --> freshness freshness --> minimization freshness --> hold minimization --> signer minimization --> hold signer --> boundary signer --> hold boundary --> manifest boundary --> hold manifest --> lane
High-consequence pathogen protocol redaction clarification packet approved for restricted dual-use review intake
A principal investigator, an institutional biosafety officer, and a secure methods-governance lead are co-producing one governed sensitive-methods redaction clarification packet because a draft protocol supplement for a high-consequence pathogen challenge study now contains procedural detail that may exceed the institution's approved disclosure boundary for aerosolization settings, environmental persistence checks, and scale-up notes. Agents help reconcile protocol revisions, containment annotations, biosafety objections, and approved redaction wording into the shared packet while preserving which disclosure questions remain contested and which residual specificity the human artifact owner accepted explicitly. The workflow ends only when the named research release owner approves that exact packet revision for one bounded restricted dual-use review intake lane, where downstream reviewers may decide whether the supplement can proceed to formal sensitive-methods review or requires narrower technical disclosure. It does not adjudicate dual-use risk, communicate with outside collaborators, or authorize protocol or manuscript submission. mermaid flowchart TD A["Draft supplement detail containment evidence reviewer comments"] B["Collaborative clarification packet current exact revision"] C["Residual objection visibility boundary notes accepted specificity"] D["Release manifest one exact packet revision one restricted intake lane"] E["Named research release owner approval decision"] F["Restricted dual-use review intake only"] A --> B B --> C B --> D C --> D D --> E E --> F
Human-subjects ethics oversight briefing revision approved for restricted IRB chair circulation
Dr. Miriam Kline, the named Director of Research Ethics Governance for the translational neurostimulation program, has already synthesized one inspectable oversight artifact: HSEO-Restricted-Brief-v4, a briefing revision summarizing protocol deviation clustering, consent-language caveats, participant complaint themes, DSMB note excerpts, site-monitor follow-ups, and unresolved chronology gaps across three active human-subjects studies. The prerequisite state is fixed before release review begins: IRB amendment register snapshot IRB-Roster-2026-03-18 is the current authority for study and reviewer scope, ethics operations SOP REO-SOP-12.7 defines the restricted chair-circulation lane, and the briefing's source-precedence appendix makes clear that approved protocol and consent records outrank site-monitor logs, which outrank study-team annotations and informal coordinator commentary. Brief revision v4 supersedes v3 after one participant complaint chronology and one consent-form version reference were refreshed, but visible blockers remain: one external site has not yet confirmed whether a translated consent insert was the active version during a reported deviation window, one DSMB excerpt still lacks final meeting-minute linkage, and one study coordinator note conflicts with the authoritative protocol deviation ledger. The workflow must decide only whether that exact briefing revision may enter the restricted IRB chair circulation lane under a manifest-bound freshness window; it does not reopen evidence synthesis, recommend protocol suspension, adjudicate noncompliance, schedule convened review, or trigger participant-contact actions. mermaid flowchart TD A["Exact ethics oversight briefing revision HSEO-Restricted-Brief-v4 ready"] --> B["Verify revision id, source-precedence appendix, freshness window, and supersession state"] B --> C{"Any stale linkage, blocked annex, or unresolved scope mismatch?"} C -- "Yes" --> D["Hold revision for refresh or supersession review"] C -- "No" --> E{"Restricted IRB chair lane, audience scope, and expiry terms valid?"} E -- "No" --> D E -- "Yes" --> F{"Dr. Miriam Kline approves exact revision for bounded chair circulation?"} F -- "No" --> D F -- "Yes" --> G["Release exact briefing revision to restricted IRB chair lane"] G --> H["Record manifest, acknowledgement, expiry, and blocked recirculation"]
Internal benchmark registry snapshot publication verification
A research-governance coordinator records that the monthly internal benchmark registry snapshot is published after the registry exporter, governed snapshot manifest, and internal discovery portal all report success for the new benchmark inventory cut. Lab leads and benchmark-review coordinators still need to know whether that claimed publication state is actually supported by the approved internal surfaces before they rely on the snapshot as the current reference for benchmark availability, lineage, and governance tags. The workflow verifies the claim against authoritative evidence and emits a bounded confirmed, disproved, or inconclusive verdict; it must not republish the snapshot, adjudicate benchmark quality, approve release of any benchmark, or launch broader remediation. mermaid flowchart TD A["Publication claim for registry snapshot recorded"] B["Check internal benchmark registry snapshot id and publication status"] C["Check governed snapshot manifest bundle id checksum set and export timestamp"] D["Check internal discovery portal snapshot revision and governance-tag summary"] E["Evaluate corroborating evidence across approved publication surfaces"] F["Confirmed publication state"] G["Disproved publication state"] H["Inconclusive publication state"] A --> B A --> C A --> D B --> E C --> E D --> E E --> F E --> G E --> H
Internally approved protocol-amendment packet to restricted pre-submission intake record handoff
A clinical research governance operations team receives an internally approved protocol-amendment packet for a multisite observational study that needs to enter a restricted pre-submission intake lane before any formal ethics submission or sponsor communication begins. The source packet combines the amendment cover memo signed by the principal investigator, a redlined protocol, revised schedule-of-events pages, updated recruitment-language excerpts, participant-risk impact notes, site-readiness confirmations, adverse-event context, and a carry-forward list of unresolved findings from the prior protocol version. The workflow must transform that heterogeneous packet into one inspectable governed intake record with required fields for study identifier, amendment type, proposed effective window, delta-from-current-protocol summary, affected participant-facing materials, source document inventory, named intake-lane owner, explicit blocker register, provenance links, and restricted-audience tags while preserving contradictions, missing approvals, and version lineage. mermaid flowchart TD INTAKE["Packet intake Internally approved protocol-amendment packet enters the restricted pre-submission lane"] EXTRACT["Field extraction and normalization Study identifier, amendment type, effective window, delta summary, affected materials, and source inventory are mapped to the intake schema"] BLOCKERS["Blocker visibility Contradictions, missing approvals, unresolved prior findings, and privacy-sensitive gaps remain explicit in the governed record"] EXCEPTION["Exception routing Blocked or ambiguous packets move to governance intake coordinator or privacy review follow-up"] HANDOFF["Restricted intake record handoff Structured pre-submission intake record is staged for Human Subjects Pre-Submission Intake"] INTAKE --> EXTRACT EXTRACT --> BLOCKERS BLOCKERS --> EXCEPTION BLOCKERS --> HANDOFF
Longitudinal survey methodology caveat board shared workbench upkeep
An internal research methods group maintains a shared methodology caveat board for a multi-wave longitudinal survey while statisticians, fieldwork coordinators, instrument owners, and reproducibility reviewers continuously log small comparability concerns that could affect later internal analysis. Updates arrive throughout the week: one analyst links a revised weighting note for a low-response subgroup, a fieldwork lead flags that one site used an older instrument wording for two days, a methods reviewer adds a caveat about translation drift in one wave, and a study coordinator reassigns ownership of an unresolved skip-logic question. The agent keeps that bounded internal board usable by refreshing source links, normalizing duplicate caveat wording, updating wave-level ownership and hold markers, and carrying unresolved comparability questions forward in a visible register without turning the board into a publication recommendation, protocol decision, or execution queue. Humans remain responsible for deciding whether a caveat is scientifically material, whether a wave should be excluded from analysis, whether weighting or documentation changes are warranted, and when any board content is mature enough to feed a separate review or publication workflow. mermaid flowchart TD A["Approved methods memos, instrument versions, and weighting notes"] B["Fieldwork operations log and site-level deployment annotations"] C["Reviewer comments and duplicate caveat wording on the shared board"] D["Shared methodology caveat board with prior ownership and hold state"] E["Agent upkeep pass for internal board refresh and normalization"] F["Updated board rows with refreshed links, normalized duplicates, and ownership markers"] G["Visible unresolved-caveat register carried forward across survey waves"] H["Methods owner review for hold-only ownership or carry-forward questions"] I["Stop and hand off if an update would imply scientific judgment or publication action"] A -->|"Refresh authoritative references first"| E B -->|"Pull deployment and incident updates"| E C -->|"Merge overlapping caveat notes"| E D -->|"Preserve prior unresolved state"| E E -->|"Refresh links, normalize duplicates, and update ownership or hold markers"| F E -->|"Carry unresolved comparability questions forward"| G G -->|"Visible hold-only follow-up"| H E -->|"Boundary-triggering request"| I
Model-serving benchmark evidence matrix shared workbench upkeep
A small applied-research team keeps an internal benchmark evidence matrix in a shared workbench while comparing model-serving platforms for future infrastructure planning. Analysts, reproducibility reviewers, and experiment owners continuously add run ids, caveat notes, hardware annotations, reviewer comments, and section ownership changes as new benchmark reruns land. The agent's role is to keep that bounded internal matrix synchronized: refresh linked experiment metadata, normalize duplicated reviewer notes, update section status markers, and carry unresolved methodology questions forward without collapsing them into a final recommendation memo. Humans remain responsible for interpreting contested results, deciding which evidence is persuasive, and choosing when any part of the matrix is mature enough to feed a separate board-facing briefing workflow. mermaid flowchart TD A["Experiment tracker new run ids and metadata"] B["Reviewer annotation surface caveats and methodology questions"] C["Shared benchmark evidence matrix current rows, owners, and lineage"] D["Agent upkeep pass bounded matrix synchronization"] E["Normalized matrix rows refreshed status and links"] F["Unresolved-question register carry-forward hold state"] G["Named analyst or reproducibility reviewer follow-up on contested items"] H["Stop and hand off to adjacent workflow if update becomes recommendation or board-facing memo"] A -->|"Refresh linked experiment metadata"| D B -->|"Normalize duplicated notes and preserve open questions"| D C -->|"Use prior matrix state owners and revision lineage"| D D -->|"Update matrix synchronization status markers and note structure"| E D -->|"Carry unresolved methodology questions forward"| F F -->|"Human follow-up on contested results"| G D -->|"Boundary-triggering request"| H
Model-serving platform benchmark briefing copilot loop
An applied-research analyst is preparing a recommendation-ready benchmark briefing for an architecture review board that must choose between three model-serving platforms for internal generative-AI workloads. The analyst uses a copilot inside a shared research workspace to iteratively tighten benchmark scope, pull source-grounded latency and cost results from the experiment tracker, compare vendor claims against internal test runs, rewrite the board memo for different stakeholder questions, and maintain an open-issues list for security and infrastructure follow-up, while the human analyst remains responsible for deciding which evidence is in scope, interpreting tradeoffs in disputed results, and approving the final briefing before it reaches engineering leadership. mermaid flowchart TD A["Analyst sets benchmark scope and evidence boundaries"] B["Copilot retrieves benchmark evidence from tracker, notebooks, and vendor docs"] C["Shared memo updates with cited findings and comparison draft revisions"] D["Analyst reviews claims, caveats, and disputed result framing"] E["Open issues list tracks security, infrastructure, and evidence gaps"] F["Human approval checkpoint for briefing package inside workspace"] A --> B B --> C C --> D D --> B D --> C D --> E E --> C C --> F
Participant consent-language variance clarification packet approved for human-subjects ethics pre-review intake
A principal investigator, a clinical research operations lead, and human-subjects governance partners are co-producing one governed consent-language variance clarification packet because translated participant-facing materials for one multisite study now diverge from the approved master consent in ways that may affect risk wording, withdrawal instructions, and compensation language. Agents help reconcile source consent versions, translator notes, site objections, and approved clarification wording into the shared packet while preserving which concerns remain contested and which edits the human artifact owner accepted. The workflow ends only when the named research release owner approves that exact packet revision for one bounded human-subjects ethics pre-review intake lane, where downstream reviewers may decide whether the variance is acceptable, needs an amendment, or requires narrower participant language. It does not decide ethics disposition, contact participants, or submit an amendment package. mermaid flowchart TD A["Source consent variants translator notes site objections"] B["Collaborative clarification packet visible contested wording accepted edits"] C["Release-manifest approval exact packet revision named release owner"] D["Human-subjects ethics pre-review intake bounded intake lane packet handoff only"] A --> B B --> C C --> B C --> D
Protocol, consent, and sample-custody use-eligibility authoritative record reconciliation
After a protocol amendment narrows permitted secondary analyses for one longitudinal biospecimen cohort and a delayed site sync leaves several records out of step, research operations discovers that current sample-use eligibility no longer agrees across the protocol registry, the participant consent ledger, the biospecimen custody inventory, and the study-operations intake tracker used to queue governed assay work. One source shows a participant's samples as eligible for genomic re-analysis under the newly approved amendment window, another still carries the pre-amendment consent scope as active, and the custody inventory matches the specimen identifiers and storage status but not the withdrawal marker and effective date now reflected in the consent ledger. Before any sample is queued for a governed assay, any dataset linkage packet is prepared, or any team decides whether the drift came from amendment timing, site processing error, or stale synchronization, the workflow must restore one trusted current use-eligibility state for each affected participant-sample record set, keep unresolved conflicts visible, stage a correction-ready package, and verify that the authoritative state is the one reflected across approved research control surfaces. mermaid flowchart TD intake["Sample-use eligibility discrepancy found across protocol registry, consent ledger, custody inventory, and intake tracker"] gather["Gather current records for the affected participant-sample set and amendment window"] compare["Compare consent scope, withdrawal markers, custody status, and effective dates under approved source precedence rules"] decision{"Do consequential eligibility fields align within approved precedence and freshness rules?"} hold["Place the participant-sample set on explicit reconciliation hold and keep unresolved conflicts visible"] ledger["Assemble one authoritative current-state eligibility ledger with field-level lineage"] package["Stage a correction package with approved write targets, rollback references, and steward review notes"] verify["Verify the authoritative state is now reflected across approved protocol, consent, custody, and intake control surfaces"] stop["Bounded stop before assay launch, dataset-linkage preparation, or participant outreach"] intake --> gather gather --> compare compare --> decision decision -->|"Yes"| ledger decision -->|"No"| hold hold --> ledger ledger --> package package --> verify verify --> stop
Publication rights and provenance clarification packet approved for publication rights review intake
A research publications lead, a data steward, and repository governance partners are co-producing one governed publication rights and provenance clarification packet because a manuscript-ready supplement now relies on legacy specimen images, derived annotations, and consortium-provided reference tables whose reuse lineage is incomplete and partially contested. Agents help reconcile deposit records, contributor agreements, repository restrictions, hold-state notes, and approved provenance wording into the shared packet while preserving which rights questions remain unresolved and which residual uncertainties the human artifact owner accepted explicitly. The workflow ends only when the named research release owner approves that exact packet revision for one bounded publication rights review intake lane, where downstream reviewers may decide whether the asset set is ready for formal rights assessment or needs narrower provenance handling. It does not adjudicate publication rights, contact outside contributors, or authorize manuscript release. mermaid flowchart TD A["Collaborative publication-rights and provenance clarification packet revision"] B["Residual rights uncertainty, provenance gaps, and hold-state visibility stay explicit"] C["Exact packet revision and release manifest prepared for approval"] D["Human research release owner approves publication-rights intake release"] E["Approved packet revision released into publication-rights review intake"] A --> B B --> C C --> D D --> E
Rare-disease registry re-identification command-bridge crisis briefing evidence synthesis
Research privacy leadership has already declared a critical registry re-identification event after disclosure-risk monitoring, access-audit review, and collaborator-handling checks show that one rare-disease cohort may now be linkable across restricted dataset exports, query activity, and draft external research materials. Before anyone recommends dataset suspension, collaborator contact, participant notification, IRB escalation, regulator outreach, root-cause investigation, or live containment action, the workflow must assemble one exact governed artifact: RDR-ReID-Command-Brief-r4. The brief has explicit prerequisites before synthesis begins: a declared critical-case scope, the current restricted command-bridge audience, the frozen affected cohort export manifest, the active consent-and-data-use restriction snapshot, the latest access-review roster, and prior brief lineage from r3. Source precedence must stay visible inside the brief: the authoritative restricted-release registry, query and download audit logs, approved disclosure-control configuration baselines, collaborator transfer manifests, and IRB-approved sharing restrictions outrank analyst notebooks, bridge chat, email summaries, or speculative study-team commentary. Visible blockers must remain open rather than being flattened into a confident narrative, including a stale collaborator receipt acknowledgment from the Zurich genomics partner, an unresolved mismatch between the query audit trail and export manifest for cohort shard RD-17, missing confirmation of whether a suppressed geography field appeared in a preprint supplement draft, and an incomplete consent-withdrawal roster refresh from one enrolling site. The workflow stops hard at reviewed crisis-brief handoff and supersession recording rather than notification, access revocation, publication intervention, causal investigation, or downstream execution. mermaid flowchart TD trigger["Critical re-identification event declared command-bridge brief requested"] --> retrieve["Retrieve current evidence release registry, audit trails, sharing restrictions, collaborator state, prior brief"] retrieve --> rank["Apply source precedence authoritative registry and audit evidence over commentary"] rank --> reconcile["Reconcile affected cohort scope, current dissemination state, and open evidence gaps"] reconcile --> draft["Assemble RDR-ReID-Command-Brief-r4 with verified facts, blockers, provenance, and freshness"] draft --> review{"Named brief owner approves exact revision for command bridge?"} review -->|"No"| hold["Hold release, record corrections, refresh stale or conflicting inputs"] hold --> retrieve review -->|"Yes"| handoff["Publish reviewed brief record supersession lineage and recipient scope"] handoff --> stop["Hard stop at crisis-briefing handoff no notification, revocation, investigation, or live containment"]
Regulatory obligation synthesis for data retention review
A privacy and records-governance team is preparing an annual review of customer-data retention obligations across support transcripts, billing records, fraud-monitoring evidence, and security logs. The workflow needs a grounded synthesis of which retention periods are mandatory, which are policy choices, and where the source material is contradictory across jurisdictions or internal standards. mermaid flowchart TD A["Scoped retrieval from approved retention sources"] B["Claim-to-source synthesis with inspectable citations"] C["Unresolved conflict surfacing for contradictory obligations"] D["Human review handoff for legal and records owners"] A --> B B --> C C --> D
Restricted interview-corpus de-identification control attestation recommendation
Dr. Lena Ortiz, the named Research Data Governance Lead for the Adolescent Sleep Resilience longitudinal study, is preparing the semiannual internal attestation for one inspectable governed artifact: ASR-IC-DEID-attestation-packet-v3, covering the restricted qualitative interview corpus used for approved secondary analysis. The prerequisite state is already fixed before review begins: IRB amendment IRB-2025-041A is active, consent addendum C-17 governs reuse boundaries for newly transcribed family-history passages, and de-identification SOP RDG-SOP-2025-06 plus transcript-redaction workspace release 2.4 are the current policy and product baselines. Source precedence is explicit inside the packet and must remain so in the recommendation: approved protocol and consent artifacts override research data-governance policy interpretations, those policy records override the curated transcript manifest and access-certification exports, and reviewer notes are advisory only when they conflict with the higher-order sources. Packet v3 supersedes v2 after a refreshed transcript manifest was attached, but visible unresolved items remain: one quote-level QA sample still uses pre-2.4 masking rules, one access-certification export predates a coordinator role transition, and it is still unclear whether the amended consent language permits retention of a small set of rare family-history quotations inside the restricted corpus. The workflow must recommend whether the attestation packet is supportable as submitted, needs targeted remediation, or should escalate for bounded interpretation before Dr. Ortiz signs the attestation or anyone alters corpus contents, access rights, or study registry records. mermaid flowchart TD A["Open attestation packet revision ASR-IC-DEID-attestation-packet-v3 for the restricted interview corpus"] --> B["Map each fixed de-identification and access-control requirement to protocol, consent, QA, roster, and corpus-manifest evidence"] B --> C{"Any stale, missing, or mismatched evidence for a non-waivable requirement?"} C -- "Yes" --> D["Recommend targeted remediation to refresh QA or access-certification evidence"] C -- "No" --> E{"Any unresolved consent-interpretation question, rare-quote exception ambiguity, or out-of-band corpus change?"} E -- "Yes" --> F["Recommend escalation to research data governance for bounded requirement interpretation"] E -- "No" --> G["Recommend packet approvable as submitted with requirement-to-evidence rationale"] D --> H["Dr. Lena Ortiz reviews the recommendation packet before any attestation sign-off or corpus action"] F --> H G --> H
Sensitive cohort dataset access recommendation packet revision approved for data access committee decision lane
A research data-governance workflow has already prepared one exact recommendation packet revision for an external collaborator's request to access a sensitive longitudinal cohort dataset. The packet narrows the bounded options to approve enclave-only access to the approved variable subset, narrow the request to synthetic or aggregate extracts pending stronger controls, or escalate to IRB and privacy review, and it keeps blocked paths such as direct row-level export or reuse outside the stated protocol explicit. Before that exact packet revision can enter the restricted data access committee decision lane, a named research governance owner must approve the committee scope, review-window expiry, and manifest binding so committee members receive the governed recommendation artifact rather than a stale or broadened copy. The workflow stops at governed release of that packet revision; it does not adjudicate the access request, provision the enclave, amend the protocol, or release any dataset. mermaid flowchart TD ready["Exact sensitive-cohort dataset-access recommendation packet revision ready"] verify["Verify packet revision id, bounded access options, and blocked paths against current evidence"] scope["Confirm data access committee lane, review-window expiry, and manifest binding"] approve["Named research governance owner reviews release or hold state"] hold["Hold packet revision for manual follow-up, scope correction, or manifest repair"] supersede["Supersede packet revision when consent scope, privacy posture, or collaborator controls change"] release["Release exact packet revision to data access committee lane with approve-enclave, narrow-extract, or escalate options"] record["Record manifest-bound handoff and block forwarding outside approved committee audience"] ready --> verify verify --> scope verify --> hold scope --> approve scope --> hold hold --> supersede approve --> release approve --> hold release --> record
Study-dataset data-use restriction board shared workbench upkeep
An internal research operations team maintains a shared data-use restriction board for a de-identified study dataset while principal investigators, privacy stewards, repository curators, and methods reviewers continuously refine what material may be reused in secondary internal analysis. Small updates arrive throughout the week: one steward links a revised consent-scope note, a curator flags a stale transcript-tag example, a reviewer adds a caveat that one coded excerpt set must stay inside a secure enclave, and a study lead reassigns ownership of an unresolved linkage-risk question. The agent keeps that bounded internal board usable by refreshing linked source references, normalizing duplicate restriction notes, updating subset ownership and hold markers, and carrying unresolved use-scope questions forward in a visible register. Humans remain responsible for deciding what the consent language actually permits, whether a restriction interpretation is correct, whether a dataset segment is safe for reuse, and when any material should move into separate approval, release, or execution workflows. mermaid flowchart TD A["Approved consent notes, privacy references, and protocol updates"] B["Reviewer annotations and duplicate restriction notes on the shared board"] C["Dataset subset inventory with owner assignments and hold markers"] D["Shared data-use restriction board with prior unresolved-question state"] E["Agent upkeep pass for bounded restriction-board refresh"] F["Updated board rows with refreshed links, normalized notes, and hold-state updates"] G["Visible unresolved-question register carried forward for follow-up"] H["Steward review for ownership-only or hold-only follow-up items"] I["Stop and hand off if a request would imply access approval or data movement"] A -->|"Refresh authoritative references first"| E B -->|"Merge overlapping restriction wording"| E C -->|"Sync subset ownership and hold context"| E D -->|"Preserve prior unresolved state"| E E -->|"Refresh links, normalize notes, and update ownership or hold markers"| F E -->|"Carry unresolved use-scope questions forward"| G G -->|"Visible follow-up for stewards"| H E -->|"Boundary-triggering request"| I